Pediatric Oncology

Overview

Pediatric oncology refers to the branch of medicine that focuses on the diagnosis and treatment of cancer in children. It is a subspecialty of hematology and oncology research that deals with the study of malignant diseases that occur in children and around the age of adolescence. While rare, childhood cancer can include various types such as leukemia, lymphoma, brain tumors, neuroblastoma, Wilms tumor, and rhabdomyosarcoma. Pediatric oncology research involves understanding how cancer develops in children and identifying new strategies to detect, diagnose, and treat it. Cancer treatments for children are different from those available for adults as children often have distinct treatment needs due to the differences in their bodies and immune systems. Pediatric oncologists work with a team of specialists including pediatricians, hematologists, radiation oncologists, and surgeons to provide the best possible care for young cancer patients. Hematology and oncology researchers in pediatric oncology study the genetic causes of childhood cancers, develop new therapies and drugs, and focus on enhancing the quality of life of survivors. They also explore ways to prevent and reduce the risks of cancer developing in children, including genetics research, immunotherapy, targeted molecular therapies, and cancer screenings. In conclusion, pediatric oncology is an important branch of hematology and oncology research that focuses on the diagnosis, treatment, and prevention of childhood cancer. Hematology and oncology researchers in this field continue to work towards developing new treatment options and improving outcomes for the youngest among us who are affected by cancer.

Research published in this journal

3 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 3 articles above have been cited 4 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

• Anti-oncogenic effects of dutasteride, a dual 5-alpha reductase inhibitor and a drug for benign prostate hyperplasia, in bladder cancer
  Jaekwon Seok et al. · 2023 · Journal of Translational Medicine
• J591 functionalized paclitaxel loaded PLGA nanoparticles successfully inhibited PSMA overexpressing LNCaP cells
  Iman Ehsan et al. · 2022 · Journal of Drug Delivery Science and Technology
• Complementary and Alternative Treatments for Cancer Prevention and Cure (Part 1)
  2019 · Journal of Experimental and Clinical Toxicology
• Extraneuraxial metastases from medulloblastoma: Single-institution outcome analyses
  T. Gupta et al. · 2018 · International Journal of Neurooncology

A sample of recent works citing this journal's research on Pediatric Oncology, linking to each citing work.

This page summarises published research for orientation; it is not medical or professional advice.

Related topics